Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03177720Phase 1Completed
Phase 1, randomised, open-label trial in pneumonia comparing Ciprofloxacin with Imipenem (2 arms). Primary endpoints: Peak Concentration at 10 hours, Area Under the Concentration Curve at 10 hours and 7 more. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03177720.